BackC4 Therapeutics Overview

C4 Therapeutics Operating Income

Operating Income for CCCC.

Quarterly Operating Income

$-27785000.00
4.73% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-113843000.00
2.33% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)